Literature DB >> 6805477

Differential induction of rat liver microsomal UDP-glucuronosyltransferase activites by various inducing agents.

W Lilienblum, A K Walli, K W Bock.   

Abstract

The selectivity of various inducers of UDP-glucuronosyltransferase was investigated in rat liver microsomes and compared with their effect on monooxygenase reactions. (1) Similar to 3-methyl-cholanthrene beta-naphthoflavone selectively stimulated the glucuronidation of 1-naphthol and 4-methylumbelliferone (GT1 substrates). (2) In contrast, DDT preferentially enhanced the glucuronidation of morphine, 4-hydroxybiphenyl (GT2 substrates) and bilirubin, similar to phenobarbital. (3) Colfibric acid and bezafibrate selectively enhanced bilirubin glucuronidation without affecting GT1 and GT2 reactions. (4) Similar to ethoxyquin and Aroclor 1254, trans-stilbene oxide enhanced both GT1 and GT2 activities but not bilirubin glucuronidation. (5) In contrast to 3-methylcholanthrene-type inducers which induce both cytochrome P-450MC and GT1, probably through a common receptor protein, ethoxyquin and trans-stilbene oxide markedly induced GT1 reactions without affecting benzo[a]pyrene monooxygenase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805477     DOI: 10.1016/0006-2952(82)90319-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  19 in total

1.  Drug metabolizing enzymes in rat hepatocytes co-cultured with cell lines.

Authors:  M T Donato; M J Gómez-Lechón; J V Castell
Journal:  In Vitro Cell Dev Biol       Date:  1990-11

2.  Co-cultures of hepatocytes with epithelial-like cell lines: expression of drug-biotransformation activities by hepatocytes.

Authors:  M T Donato; J V Castell; M J Gómez-Lechón
Journal:  Cell Biol Toxicol       Date:  1991-01       Impact factor: 6.691

3.  Immunochemical analysis of uridine diphosphate-glucuronosyltransferase in four patients with the Crigler-Najjar syndrome type I.

Authors:  H H van Es; B G Goldhoorn; M Paul-Abrahamse; R P Elferink; P L Jansen
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Isolation and characterization of multiple forms of rat liver UDP-glucuronate glucuronosyltransferase.

Authors:  J Roy Chowdhury; N Roy Chowdhury; C N Falany; T R Tephly; I M Arias
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

5.  Drug-metabolizing enzyme activities in freshly isolated oval cells and in an established oval cell line from carcinogen-fed rats.

Authors:  P Steinberg; R Steinbrecher; D Schrenk; P Munzel; M Bruck; H Gschaidmaier; F Oesch; K W Bock
Journal:  Cell Biol Toxicol       Date:  1994-02       Impact factor: 6.691

6.  Carrier-mediated transport of uridine diphosphoglucuronic acid across the endoplasmic reticulum membrane is a prerequisite for UDP-glucuronosyltransferase activity in rat liver.

Authors:  X Bossuyt; N Blanckaert
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

7.  Effects of steroid hormones and xenobiotics on the pubertal development of UDP-glucuronosyltransferase activities towards androsterone and 4-nitrophenol in Wistar rats.

Authors:  H K Watanabe; M Matsui
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

8.  Expression of a high-affinity form of UDP-glucuronosyltransferase in human foetal liver cells in culture on exposure to mercuric chloride.

Authors:  T M Tan; K P Wong; K H Sit
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

9.  Comparison of benzo(a)pyrene metabolism in isolated perfused rat lung and liver.

Authors:  M Mollière; H Foth; R Kahl; G F Kahl
Journal:  Arch Toxicol       Date:  1987-06       Impact factor: 5.153

10.  Glucuronidation of the mycotoxins alternariol and alternariol-9-methyl ether in vitro: chemical structures of glucuronides and activities of human UDP-glucuronosyltransferase isoforms.

Authors:  E Pfeiffer; C Schmit; B Burkhardt; M Altemöller; J Podlech; M Metzler
Journal:  Mycotoxin Res       Date:  2008-12-23       Impact factor: 3.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.